Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2003 2
2005 2
2006 5
2008 2
2009 3
2010 2
2011 4
2012 3
2013 5
2016 4
2017 3
2018 4
2019 2
2020 1
2021 1
2022 4
2023 2

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Results by year

Filters applied: . Clear all
Page 1
Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut.
Groeger D, O'Mahony L, Murphy EF, Bourke JF, Dinan TG, Kiely B, Shanahan F, Quigley EM. Groeger D, et al. Gut Microbes. 2013 Jul-Aug;4(4):325-39. doi: 10.4161/gmic.25487. Epub 2013 Jun 21. Gut Microbes. 2013. PMID: 23842110 Free PMC article. Clinical Trial.
Additionally, the effect of B. infantis 35624 on immunological biomarkers in healthy subjects (n = 22) was assessed. ...Furthermore, in healthy subjects, LPS-stimulated TNF-alpha and IL-6 secretion by peripheral blood mononuclear cells (PBMCs) was significantly reduced in …
Additionally, the effect of B. infantis 35624 on immunological biomarkers in healthy subjects (n = 22) was assessed. ...Furthermore, …
Bifidobacterium infantis 35624: a novel probiotic for the treatment of irritable bowel syndrome.
Brenner DM, Chey WD. Brenner DM, et al. Rev Gastroenterol Disord. 2009 Winter;9(1):7-15. Rev Gastroenterol Disord. 2009. PMID: 19367213 Review.
Although their exact mechanisms of action remain elusive, it is clear that the beneficial properties inherent to each probiotic species are strain specific. Bifidobacterium infantis 35624 ( B infantis 35624; Bifantis, The Procter & Gamble Company, Cincinn …
Although their exact mechanisms of action remain elusive, it is clear that the beneficial properties inherent to each probiotic species are …
Efficacy of Bifidobacterium infantis 35624 in patients with irritable bowel syndrome: a meta-analysis.
Yuan F, Ni H, Asche CV, Kim M, Walayat S, Ren J. Yuan F, et al. Curr Med Res Opin. 2017 Jul;33(7):1191-1197. doi: 10.1080/03007995.2017.1292230. Epub 2017 Mar 7. Curr Med Res Opin. 2017. PMID: 28166427 Review.
Previous clinical trials to examine the efficacy of probiotic Bifidobacterium infantis 35624 (B. infantis) in patients with IBS have shown inconsistent findings. ...
Previous clinical trials to examine the efficacy of probiotic Bifidobacterium infantis 35624 (B. infantis) in patients with IB …
Effect of Bifidobacterium longum 35624 on disease severity and quality of life in patients with irritable bowel syndrome.
Sabaté JM, Iglicki F. Sabaté JM, et al. World J Gastroenterol. 2022 Feb 21;28(7):732-744. doi: 10.3748/wjg.v28.i7.732. World J Gastroenterol. 2022. PMID: 35317278 Free PMC article.
BACKGROUND: Bifidobacterium longum 35624 has shown efficacy in improving irritable bowel syndrome (IBS) symptoms compared with placebo in double-blind randomized studies. However, few data are available from real-life clinical practice or from studies that used Rome …
BACKGROUND: Bifidobacterium longum 35624 has shown efficacy in improving irritable bowel syndrome (IBS) symptoms compared with …
An Exopolysaccharide Produced by Bifidobacterium longum 35624® Inhibits Osteoclast Formation via a TLR2-Dependent Mechanism.
Wallimann A, Hildebrand M, Groeger D, Stanic B, Akdis CA, Zeiter S, Richards RG, Moriarty TF, O'Mahony L, Thompson K. Wallimann A, et al. Calcif Tissue Int. 2021 May;108(5):654-666. doi: 10.1007/s00223-020-00790-4. Epub 2021 Jan 3. Calcif Tissue Int. 2021. PMID: 33388801
The probiotic Bifidobacterium longum subsp. longum 35624 (B. longum 35624), with its surface exopolysaccharide (EPS624), has previously been demonstrated to induce immunoregulatory responses in the host and may, therefore, be a novel approach to prevent bone …
The probiotic Bifidobacterium longum subsp. longum 35624 (B. longum 35624), with its surface exopolysaccharide (EPS624) …
The probiotic Bifidobacterium infantis 35624 displays visceral antinociceptive effects in the rat.
McKernan DP, Fitzgerald P, Dinan TG, Cryan JF. McKernan DP, et al. Neurogastroenterol Motil. 2010 Sep;22(9):1029-35, e268. doi: 10.1111/j.1365-2982.2010.01520.x. Epub 2010 Jun 1. Neurogastroenterol Motil. 2010. PMID: 20518856
METHODS: Following 14 days oral gavage of Lactobacillus salivarius UCC118, Bifidobacterium infantis 35624, or Bifidobacterium breve UCC2003 both SD and WKY rats were exposed to a novel stress, the open field arena and their behavior was recorded. ...CONCLUSIO …
METHODS: Following 14 days oral gavage of Lactobacillus salivarius UCC118, Bifidobacterium infantis 35624, or Bifidobacteri …
An 8-Week Course of Bifidobacterium longum 35624® Is Associated with a Reduction in the Symptoms of Irritable Bowel Syndrome.
Lenoir M, Wienke J, Fardao-Beyler F, Roese N. Lenoir M, et al. Probiotics Antimicrob Proteins. 2023 Sep 13. doi: 10.1007/s12602-023-10151-w. Online ahead of print. Probiotics Antimicrob Proteins. 2023. PMID: 37702965
The objective of the present study was to evaluate the effectiveness and tolerability of a probiotic (Bifidobacterium longum 35624()) in adults (aged 18 or over) with IBS (as defined by the Rome IV criteria). ...Thirty-seven patients were included. The course of B. …
The objective of the present study was to evaluate the effectiveness and tolerability of a probiotic (Bifidobacterium longum 35624 …
Probiotic treatment (Bifidobacterium longum subsp. longum 35624™) affects stress responsivity in male rats after chronic corticosterone exposure.
Haas GS, Wang W, Saffar M, Mooney-Leber SM, Brummelte S. Haas GS, et al. Behav Brain Res. 2020 Sep 1;393:112718. doi: 10.1016/j.bbr.2020.112718. Epub 2020 May 30. Behav Brain Res. 2020. PMID: 32485204
Therefore, the current study investigates the effects of chronic administration of the commercially available probiotic Bifidobacterium longum subsp. longum 35624(B. 35624) to male and female rats under control or "stressed" conditions. ...Rats were sacrifice …
Therefore, the current study investigates the effects of chronic administration of the commercially available probiotic Bifidobacterium …
Bifidobacterium infantis 35624 protects against salmonella-induced reductions in digestive enzyme activity in mice by attenuation of the host inflammatory response.
Symonds EL, O'Mahony C, Lapthorne S, O'Mahony D, Sharry JM, O'Mahony L, Shanahan F. Symonds EL, et al. Clin Transl Gastroenterol. 2012 May 10;3(5):e15. doi: 10.1038/ctg.2012.9. Clin Transl Gastroenterol. 2012. PMID: 23238232 Free PMC article.
The objective of this study was to determine the mechanism by which different doses and durations of Salmonella infection and lipopolysaccharide (LPS) affect brush border enzyme activity in the mouse, and to determine if the probiotic Bifidobacterium longum subspecies infa …
The objective of this study was to determine the mechanism by which different doses and durations of Salmonella infection and lipopolysaccha …
46 results